Question 1

What is the catalog number for Human RSPO3 Antibody, InVivo Block/Neutralizing Antibody?

Accepted Answer

The catalog number for Human RSPO3 Antibody, InVivo Block/Neutralizing Antibody is ANT-37401-100ug.

Question 2

What sizes are available for Human RSPO3 Antibody, InVivo Block/Neutralizing Antibody?

Accepted Answer

Human RSPO3 Antibody, InVivo Block/Neutralizing Antibody is available in the following size(s): 100 µg.

Question 3

Is Human RSPO3 Antibody, InVivo Block/Neutralizing Antibody in stock?

Accepted Answer

Human RSPO3 Antibody, InVivo Block/Neutralizing Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 5

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 6

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

Human RSPO3 Antibody, InVivo Block/Neutralizing Antibody

Product Specifications

Type

Classification

Frequently Asked Questions

Explore Other Products

HER-2 / CD340 (HRB2/718), CF740 conjugate, 0.1mg/mL

PAX5 / BSAP (Early B-Cell Marker) (PAX5/2060), CF740 conjugate, 0.1mg/mL

TIGIT / VSTM3 / VSIG9 (Immune Checkpoint for Cancer) (TIGIT/3017), CF640R conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, 0.1mg/mL

Epstein-Barr Virus (LMP-1) (CS1-4), CF405S conjugate, 0.1mg/mL

CD71 (66IG10), CF488A conjugate, 0.1mg/mL